⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 5, 2024Journal of Ovarian ResearchOpen Access

Enhancing angiogenesis and inhibiting apoptosis: evaluating the therapeutic efficacy of bone marrow mesenchymal stem cell-derived exosomes in a DHEA-induced PCOS mouse model

Xiaojing Teng Zhiyi Wang Xiaolei Wang

View Full Paper

Ask AI

Bookmark

Share

Abstract

Polycystic Ovary Syndrome (PCOS) is a widespread endocrine disorder among women, characterized by symptoms like ovarian cysts, hormonal imbalance, and metabolic issues. This research evaluates the therapeutic potential of Bone Marrow Mesenchymal Stem Cell-derived exosomes (BMSC-Exo) in treating PCOS symptoms within a mouse model.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Teng et al. (2024) studied this question.

synapsesocial.com/papers/68e65f93b6db6435875ed81a https://doi.org/10.1186/s13048-024-01445-w

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Mesenchymal stem cells-derived exosomes as a promising new approach for the treatment of infertility caused by polycystic ovary syndromeOriginal Research · 2022 · 26 citations
2The therapeutic potential of exosomes derived from mesenchymal stem cells for premature ovarian failure: A systematic.Clinical Trial · 2026 · 1 citations
3Efficacy and Safety of Human Umbilical Cord Mesenchymal Stem Cells in Improving Fertility in Polycystic Ovary Syndrome Mice2024 · 3 citations
4Mesenchymal stem cells reverse ovarian dysfunction by inhibiting autophagy in polycystic ovary syndrome miceOriginal Research · 2026
5Use of placental-derived mesenchymal stem cells to restore ovarian function and metabolic profile in a rat model of the polycystic ovarian syndrome2024 · 11 citations